Skip to main content

Table 2 Treatment outcomes at six months after NovaSure™ endometrial ablation: outpatient local anaesthetic treatment versus day-case general anaesthetic treatment

From: Outpatient versus day-case endometrial ablation using the NovaSure™ impedance-controlled ablative system

Outcome measure*

Inpatient (n=13)

Outpatient (n=17)

Periods now

 • Amenorrhoea

6/13 (46%)

5/17 (29%)

 • Spotting

2/13 (15%)

3/17 (18%)

 • Light

0/13 (0%)

4/17 (24%)

 • Moderate

3/13 (23%)

5/17 (29%)

 • Heavy

2/13 (15%)

0/17 (0%)

Satisfied

 • Yes

11/13 (85%)

14/17 (82%)

 • No

2/13 (15%)

3/17 (18%)

Menstrual bleeding post-treatment

 • Much better

10/13 (76%)

13/17 (76%)

 • A little better

1/13 (8%)

3/17 (18%)

 • Same

1/13 (8%)

1/17 (6%)

 • Worse

1/13 (8%)

 

Dysmenorrhoea post-treatment

 • Never had it

0/13 (0%)

3/17 (18%)

 • Much better

6/13 (46%)

6/14 (43%)

 • A little better

2/13 (15%)

4/14 (29%)

 • Same

2/13 (15%)

2/14 (14%)

 • Worse

3/13 (23%)

2/14 (14%)

Recommend to a friend

 • Definitely

8/13 (62%)

12/17 (71%)

 • Definitely, under general anaesthetic

0/13 (0%)

1/17 (6%)

 • Probably

2/13 (15%)

3/17 (18%)

 • Not sure

1/13 (8%)

1/17 (6%)

 • Probably not

1/13 (8%)

0/13 (0%)

 • Definitely not

1/13 (8%)

0/13 (0%)

  1. *No statistical difference (P>0.05) between inpatient and outpatient treatment for any clinical outcomes at six months (Fisher’s exact test)